| meta-analysis | Q815382 |
| systematic review | Q1504425 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/APT.12900 |
| P8608 | Fatcat ID | release_tgqixy4vwrbpnmkmxaiabsar2q |
| P3181 | OpenCitations bibliographic resource ID | 3734783 |
| P698 | PubMed publication ID | 25099956 |
| P5875 | ResearchGate publication ID | 264537050 |
| P50 | author | Ming-Hua Zheng | Q37831296 |
| Gui-qi Zhu | Q42757517 | ||
| Keqing Shi | Q59704601 | ||
| P2093 | author name string | H Zou | |
| M Braddock | |||
| Y-P Chen | |||
| L-R Wang | |||
| Y-Q Lin | |||
| J You | |||
| P2860 | cites work | Cancer statistics, 2010 | Q27860525 |
| Cancer statistics, 2012 | Q27860574 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860749 | ||
| Practical methods for incorporating summary time-to-event data into meta-analysis | Q28131754 | ||
| Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study | Q33506777 | ||
| Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial | Q33600403 | ||
| Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. | Q33865150 | ||
| Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma | Q33961798 | ||
| Improved survival in resected biliary malignancies | Q34156918 | ||
| Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial | Q34332808 | ||
| Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. | Q34637757 | ||
| Bayesian methods for evidence synthesis in cost-effectiveness analysis | Q36381197 | ||
| Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study | Q36760924 | ||
| Use of indirect and mixed treatment comparisons for technology assessment | Q37259556 | ||
| Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009 | Q37347327 | ||
| Efficacy of gemcitabine plus platinum agents for biliary tract cancers: a meta-analysis | Q38116877 | ||
| Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses | Q39735046 | ||
| Targeted therapy for biliary-tract cancer | Q43175236 | ||
| Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma | Q43232290 | ||
| Adjuvant chemo-radiotherapy in ampullary cancers | Q45255754 | ||
| Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience | Q45881932 | ||
| Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. | Q46894544 | ||
| Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater | Q46916350 | ||
| Quality of life after adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled study | Q48925522 | ||
| Diagnosis and treatment of cholangiocarcinoma. | Q52946913 | ||
| A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer. | Q53516340 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| systematic review | Q1504425 | ||
| ??? | Q18556397 | ||
| P304 | page(s) | 759-770 | |
| P577 | publication date | 2014-10-01 | |
| P1433 | published in | Alimentary Pharmacology & Therapeutics | Q4726656 |
| P1476 | title | Systematic review with network meta-analysis: adjuvant therapy for resected biliary tract cancer | |
| P478 | volume | 40 |
| Q35778052 | A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis. |
| Q41709095 | A network meta-analysis on the efficacy of targeted agents in combination with chemotherapy for treatment of advanced/metastatic triple-negative breast cancer |
| Q98159783 | Adjuvant chemoradiotherapy for positive hepatic ductal margin on cholangiocarcinoma |
| Q96950563 | Clinical impact of irreversible electroporation ablation for unresectable hilar cholangiocarcinoma |
| Q58759141 | Comparison of apatinib and capecitabine (Xeloda) with capecitabine (Xeloda) in advanced triple-negative breast cancer as third-line therapy: A retrospective study |
| Q47129097 | DCK expression, a potential predictive biomarker in the adjuvant gemcitabine chemotherapy for biliary tract cancer after surgical resection: results from a phase II study |
| Q55381085 | EGFR Target Therapy Combined with Gemox for Advanced Biliary Tract Cancers: a Meta-analysis based on RCTs. |
| Q28078111 | HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists |
| Q37333804 | Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma. |
| Q36884377 | Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients |
| Q26824664 | Network meta-analysis of randomized controlled trials: efficacy and safety of UDCA-based therapies in primary biliary cirrhosis |
| Q35660038 | Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis |
| Q28087211 | Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis |
| Q54210722 | Prognostic factors for operable biliary tract cancer: serum levels of lactate dehydrogenase, a strong association with survival. |
| Q26768128 | Systematic Review and Network Meta-Analysis of Randomized Controlled Trials: Comparative Effectiveness and Safety of Direct-Acting Antiviral Agents for Treatment-Naive Hepatitis C Genotype 1 |
Search more.